- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 86.49M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 88.17M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $21.36M |
| Capex | Q1 2026 · Mar 31, 2026 | $13.82M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $7.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $23.83M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $159.27M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $253.64M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $113.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.86B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.57B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $265.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $199.99M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $274.06M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $144.79M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.96B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.68B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.21 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $12.75M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $29.2M |
| Net Income | Q1 2026 · Mar 31, 2026 | $177.8M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $18.25M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $160.79M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$29.63M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $21.61M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $16.29M |